Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CHOP vs R-CLOP in Elderly Aggressive Lymphoma
NCT00536393Phase 3Completed
- Sponsor
- French Innovative Leukemia Organisation
- Start
- Oct 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin in diffuse large B-cell lymphoma (DLBCL), sponsored by French Innovative Leukemia Organisation. Started Oct 2000; status: completed.
02
Drugs
doxorubicin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00536393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536393.